Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Hanne Lenaerts
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
7
Results
2025
Design and evaluation of universal control antisense oligonucleotides across cellular models
Edith De Bruycker
Manon Bouckaert
Emma Delanote
Leander Meuris
Hanne Lenaerts
Lode Denolf
Katrien Remaut
An Staes
Kris Gevaert
Steve Lefever
et al.
C3
Conference
2025
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR variant in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Birthe Hilgen
Maria Georgiou
Filip Van Den Broeck
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
et al.
U
Conference
2025
Generation of two iPSC lines (UGENTi003 and UGENTi004) from patients with intermediate rod-cone dystrophy carrying the c.[-123C>T;701G>A]; [806_810del] variants in the RDH12 gene
Manon Bouckaert
Filip Van Den Broeck
M. Ghazvini
Alfredo Dueñas Rey
Hanne Lenaerts
Annelies Dheedene
Kathleen Claes
Elfride De Baere
Bart Leroy
Julie De Zaeytijd
et al.
A1
Journal Article
in
STEM CELL RESEARCH
2025
2024
Combining a prioritization strategy and functional studies nominates 5'UTR variants underlying inherited retinal disease
Alfredo Dueñas Rey
Marta del Pozo Valero
Manon Bouckaert
Katherine A. Wood
Filip Van Den Broeck
Malena Daich Varela
Huw B. Thomas
Mattias Van Heetvelde
Marieke De Bruyne
Stijn Van de Sompele
et al.
A1
Journal Article
in
GENOME MEDICINE
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Maria Georgiou
Filip Van Den Broeck
Margot De Moor
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
et al.
C3
Conference
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Birthe Hilgen
Maria Georgiou
Filip Van Den Broeck
Margot De Moor
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
et al.
C3
Conference
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Maria Georgiou
Filip Van Den Broeck
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
Elfride De Baere
et al.
C3
Conference
2024